Transcranial Magnetic Stimulation For Parkinson's Disease
Published on: August 1, 2024
transcranial magnetic stimulation for parkinson's disease featured image

Introduction

Parkinson's Disease is a neurological disorder characterised by symptoms such as tremors, rigidity, and difficulty with movement and coordination.1 One potential treatment option for Parkinson's Disease is transcranial magnetic stimulation (TMS). TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain. It has shown potential in helping regulate brain activity and reduce symptoms associated with various neurological disorders, including Parkinson's Disease.

Understanding parkinson’s disease

Parkinson's Disease is a progressive neurological disorder that affects movement and can also cause a variety of non-motor symptoms. It is caused by the loss of dopamine-producing nerve cells (neurons) in the brain, particularly in a region of the brain called the substantia nigra.2 Dopamine is a neurotransmitter that regulates movement and coordination. As the neurons degenerate, it reduces dopamine levels, impairing motor skills.1,2 

Common motor symptoms of Parkinson's Disease include:2

  • Tremors (involuntary shaking of the body)
  • Rigidity 
  • Bradykinesia (slowed movement)
  • Postural instability

In addition to motor symptoms, individuals may also experience a range of non-motor symptoms including:2,3

The symptoms of Parkinson's Disease can vary widely among individuals and may progress at different rates, making it challenging to manage them effectively.

While there is currently no cure for Parkinson's Disease, there are treatments available to help reduce symptoms and improve quality of life. These treatments typically aim to increase dopamine levels in the brain, enhance dopamine function, or manage symptoms through other paths. Current treatment options for Parkinson's Disease include medications, such as levodopa and dopamine agonists, as well as deep brain stimulation (DBS) surgery.3,4 However, these treatments are not capable of stopping the progression of Parkinson’s entirely. 

What is transcranial magnetic stimulation (TMS)?

Transcranial Magnetic Stimulation (TMS) is a painless and non-invasive method that uses magnetic fields to stimulate specific parts of the brain.5,6 It involves placing a coil against the scalp and sending short bursts of magnetic energy to targeted brain areas. This creates tiny electrical currents in the brain that can change how the brain's nerve cells work, affecting things like movement, thinking, and mood.6 Depending on how it is used, TMS can be used to diagnose or treat brain conditions. It is typically performed in outpatient settings and does not require anaesthesia, making it a convenient procedure.5

How TMS can benefit parkinson's disease patients

Studies suggest that TMS may help alleviate motor symptoms and improve overall motor function in individuals with Parkinson’s Disease.7 The precise mechanisms underlying the therapeutic effects of TMS in Parkinson's disease are, however, not fully understood: It is thought to involve cortical excitability as well as dopamine release and to fix damaged neural circuits.7,8 Clinical studies have shown promising results, with patients improving motor symptoms, gait, and balance. Additionally, TMS may also have protective effects on the brain and slow the progression of Parkinson’s in some patients.7,8 

Limitations and challenges of TMS for parkinson's disease

​​Using TMS to treat Parkinson's Disease may be beneficial, but it comes with particular challenges. One major challenge is that not every individual responds to TMS equally. Factors like how severe the disease is, how long the individual has had the disease, and differences in brain structure and function can affect how well TMS works for each individual.9 Additionally, the best way to use TMS, such as how often and how strong the magnetic pulses should be, differs for each individual.9 These factors make TMS more complex than having a one-size-fits-all approach for Parkinson's Disease.

There are some important safety concerns and potential side effects to consider with TMS: It is generally safe but can cause mild side effects like headaches, scalp discomfort, or temporary changes in mood or thinking.10,11 In rare cases, more serious effects like seizures might happen, especially for individuals with a history of epilepsy or other brain conditions. However, the chances of having a seizure are low, with less than 1 in 100 patients.10,11 It is still essential to be monitored carefully and take the right precautions during TMS treatment to lower the risk of any problems.

Accessibility and cost are also important challenges that slow down the widespread use of TMS for treating Parkinson's Disease. TMS requires special equipment and trained healthcare staff, which might not be available in all healthcare centres. Additionally, the costs of TMS treatments can be expensive for some patients, particularly if not covered by insurance. In the United Kingdom, treatment with TMS is available on the NHS for neurological disorders but is more widely available under private organisations.

Although TMS can help alleviate symptoms in some individuals with Parkinson's Disease, it doesn't cure the underlying condition. The benefits of TMS usually last for a short time and may need regular treatment sessions to keep working.11 Long-term research studies are needed to understand if TMS can slow down the progression of Parkinson's Disease or improve long-term outcomes.

Future directions and research in TMS for parkinson's disease

Even though there are difficulties, ongoing research and clinical trials are being conducted to explore TMS and how it can help treat Parkinson's Disease. There have also been efforts to improve the technology needed for TMS, such as creating new designs for the coils which can help determine the best way to use TMS.7 This research will hopefully also indicate who might benefit the most from TMS and how to make the treatment more personalised for each patient. 

Summary

TMS looks promising as a treatment option for Parkinson's Disease that is both safe and does not involve surgery. While it has shown positive results in helping with movement problems and overall function in Parkinson's patients, there is still a need for more research to understand exactly how it works and to ensure that it is being used in the most effective way possible. Here, it is important to ensure that TMS is safe, the treatment process is consistent, and more people can access it as a treatment. With ongoing research and collaboration, TMS can make a big difference in the lives of those with Parkinson's Disease.

FAQs

How does TMS compare to other treatments for parkinson's disease? 

TMS is a non-invasive way to treat Parkinson's Disease, unlike traditional medications or DBS surgery. While medication can help by increasing dopamine levels, TMS works by changing brain activity using magnets. DBS, on the other hand, requires surgery to implant electrodes in the brain to send electrical signals.12

Are there specific criteria for determining if you are a good candidate for TMS therapy?

Whether someone is a good fit for TMS therapy depends on several things like how severe their Parkinson's Disease is, what symptoms they have, and their overall health. Usually, people who might benefit from TMS have serious symptoms of Parkinson's Disease that are not improving with medication alone. However, the exact criteria might differ based on what healthcare providers in your area typically do and what the currently approved research suggests.

What are the potential long-term effects of TMS treatment for parkinson's disease symptoms and disease progression?

TMS has shown some promising short-term results in helping with movement issues and overall function in Parkinson's Disease, but it is still unclear how it affects the disease in the long run.6,7 Some research suggests TMS may slow down the disease in some individuals by protecting the brain. However, more research is needed to see if these benefits last over time and how TMS affects Parkinson's as it progresses.

How does TMS therapy fit into a comprehensive treatment plan for parkinson's disease? 

TMS therapy can be part of a complete treatment plan for Parkinson's Disease, along with taking medication, doing physical therapy, and making lifestyle changes. TMS can help with specific symptoms or improve how the brain works overall. It can be used as a standalone therapy or along with other treatments to better manage symptoms and improve the quality of life for individuals with Parkinson's Disease.

Are there any potential risks or limitations associated with combining TMS therapy with other treatments for parkinson's disease?

Although TMS is usually safe, there could be some risks if it is used along with other treatments or interventions for Parkinson's Disease. For instance, pairing TMS with certain medications might raise the chances of side effects or interactions. Also, people with specific medical conditions may not be suitable candidates for TMS therapy.11 It is crucial to talk to your healthcare providers to understand the potential risks and benefits before combining TMS with other treatments.

What are the potential implications of TMS therapy for different stages of parkinson's disease?

The impact of TMS therapy might differ based on the type and stage of Parkinson's Disease an individual has. It could be helpful for individuals with certain symptoms or types of the disease, such as if someone has lots of tremors or their symptoms don't respond well to medication.10 Additionally, TMS might work differently depending on whether an individual is in the early or later stages of Parkinson's. More research is needed to understand exactly how TMS can help different types and stages of Parkinson's Disease.

References

  1. Parkinson’s disease. nhs.uk [Internet]. 2017 [cited 2024 Feb 26]. Available from: https://www.nhs.uk/conditions/parkinsons-disease/.
  2. Parkinson’s Disease: Causes, Symptoms, and Treatments. National Institute on Aging [Internet]. [cited 2024 Feb 26]. Available from: https://www.nia.nih.gov/health/parkinsons-disease/parkinsons-disease-causes-symptoms-and-treatments.
  3. Parkinson disease [Internet]. [cited 2024 Feb 26]. Available from: https://www.who.int/news-room/fact-sheets/detail/parkinson-disease.
  4. Gandhi KR, Saadabadi A. Levodopa (L-Dopa). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK482140/
  5. Transcranial Magnetic Stimulation. East London NHS Foundation Trust [Internet]. [cited 2024 Feb 26]. Available from: https://www.elft.nhs.uk/transcranial-magnetic-stimulation.
  6. Eldaief MC, Press DZ, Pascual-Leone A. Transcranial magnetic stimulation in neurology. Neurol Clin Pract [Internet]. 2013 [cited 2024 Feb 26]; 3(6):519–26. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863979/.
  7. Najib U, Bashir S, Edwards D, Rotenberg A, Pascual-Leone A. Transcranial Brain Stimulation: Clinical Applications and Future Directions. Neurosurg Clin N Am [Internet]. 2011 [cited 2024 Feb 26]; 22(2):233–ix. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547606/
  8. Wagle Shukla A, Shuster JJ, Chung JW, Vaillancourt DE, Patten C, Ostrem J, et al. Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis. PM&R [Internet]. 2016 [cited 2024 Feb 26]; 8(4):356–66. Available from: https://www.sciencedirect.com/science/article/pii/S1934148215009703.
  9. Chou Y, Hickey PT, Sundman M, Song AW, Chen N. Effects of Repetitive Transcranial Magnetic Stimulation on Motor Symptoms in Parkinson Disease: A Systematic Review and Meta-analysis. JAMA Neurology [Internet]. 2015 [cited 2024 Feb 26]; 72(4):432–40. Available from: https://doi.org/10.1001/jamaneurol.2014.4380
  10. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol [Internet]. 2009 [cited 2024 Feb 26]; 120(12):2008–39. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260536/.
  11. VonLoh M, Chen R, Kluger B. Safety of transcranial magnetic stimulation in Parkinson’s disease: A review of the literature. Parkinsonism & Related Disorders [Internet]. 2013 [cited 2024 Feb 26]; 19(6):573–85. Available from: https://www.sciencedirect.com/science/article/pii/S1353802013000242
  12. Deep brain stimulation. Parkinson’s UK [Internet]. 2023 [cited 2024 Feb 28]. Available from: https://www.parkinsons.org.uk/information-and-support/deep-brain-stimulation.
Share

Rhiannon Skye Kozel

Final year Bachelors of Science in Pharmacology (Hons) – University of Edinburgh, Scotland

Rhiannon is a final year Pharmacology student with a keen interest in infectious diseases and personalised medicine. She has experience in the clinical microbiology laboratory. Rhiannon is passionate about contributing to advancements in healthcare and is committed to making a positive impact through her academic and professional pursuits.

arrow-right